光化性角化病

Berman B, Bienstock L, Kuritzky L, et al. Primary Care Education Consortium; Texas Academy of Family Physicians. Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel. J Fam Pract. 2006;55(suppl):1-8.

• 摘要

Schwartz RA. The actinic keratosis. A perspective and update. Dermatol Surg. 1997;23:1009-1019.

• 摘要

Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol. 1994;131:455-464.

• 摘要

de Berker D, McGregor JM, Hughes BR; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156:222-230.

• 全文
• 摘要

Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin. 2002;20:378-385.

• 摘要

Gupta AK, Paquet M, Villanueva E, et al. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;(12):CD004415.

• 全文
• 摘要

Lebwohl M, Swanson N, Anderson LL, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010-1019.

• 全文
• 摘要

1.  Moy R. Clinical presentation of actinic keratosis and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1 Suppl):S8-S10.

• 摘要

2.  Berman B, Bienstock L, Kuritzky L, et al. Primary Care Education Consortium; Texas Academy of Family Physicians. Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel. J Fam Pract. 2006;55(suppl):1-8.

• 摘要

3.  Hawrot A, Alam M, Ratner D. Squamous cell carcinoma. Curr Probl Dermatol. 2003;15:91-133.

4.  Schwartz RA. The actinic keratosis. A perspective and update. Dermatol Surg. 1997;23:1009-1019.

• 摘要

5.  Kuflik AS, Schwartz RA. Actinic keratosis and squamous cell carcinoma. Am Fam Physician. 1994;49:817-820.

• 摘要

6.  Chung HJ, McGuigan KL, Osley KL, et al. Pigmented solar (actinic) keratosis: an underrecognized collision lesion. J Am Acad Dermatol. 2013;68:647-653.

• 摘要

7.  Yu RC, Pryce DW, Macfarlane AW, et al. A histopathological study of 643 cutaneous horns. Br J Dermatol. 1991;124:449-452.

• 摘要

8.  Schosser RH, Hodge SJ, Gaba CR, et al. Cutaneous horns: a histopathologic study. South Med J. 1979;72:1129-1131.

• 摘要

9.  Hemminki K, Zhang H, Czene K. Time trends and familial risks in squamous cell carcinoma of the skin. Arch Dermatol. 2003;139:885-889.

• 全文
• 摘要

10.  Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(suppl 61):1-6.

• 摘要

11.  Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294:681-690.

• 全文
• 摘要

12.  Anwar J, Wrone DA, Kimyai-Asadi A, et al. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes. Clin Dermatol. 2004;22:189-196.

• 摘要

13.  Helfand M, Gorman AK, Mahon S, et al; US Department of Health and Human Services. Actinic keratoses: final report. May 2001. http://www.cms.gov/ (last accessed 26 September 2016).

• 全文

14.  Lookingbill DP, Lookingbill GL, Leppard B. Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care program. J Am Acad Dermatol. 1995;32:653-658.

• 摘要

15.  Lehmann AR, Bridges BA. Sunlight-induced cancer: some new aspects and implications of the xeroderma pigmentosum model. Br J Dermatol. 1990;122(suppl 35):115-119.

• 摘要

16.  Lambert WC, Kuo HR, Lambert MW. Xeroderma pigmentosum. Dermatol Clin. 1995;13:169-209.

• 摘要

17.  Luande J, Henschke CI, Mohammed N. The Tanzanian human albino skin. Natural history. Cancer. 1985;55:1823-1828.

• 摘要

18.  Memon AA, Tomenson JA, Bothwell J. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol. 2000;142:1154-1159.

• 摘要

19.  Zagula-Mally ZW, Rosenberg EW, Kashgarian M. Frequency of skin cancer and solar keratoses in a rural southern county as determined by population sampling. Cancer. 1974;34:345-349.

• 摘要

20.  Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol. 2000;115:273-277.

• 全文
• 摘要

21.  Green A, Beardmore G, Hart V, et al. Skin cancer in a Queensland population. J Am Acad Dermatol. 1988;19:1045-1052.

• 摘要

22.  Cooper KD, Fox P, Neises G, et al. Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of Langerhans cell-dependent function is followed by the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation. J Immunol. 1985;134:129-137.

• 摘要

23.  Granstein RD, Askari M, Whitaker D, et al. Epidermal cells in activation of suppressor lymphocytes: further characterization. J Immunol. 1987;138:4055-4062.

• 摘要

24.  Winkelmann, Baldes EJ, Zollman PE. Squamous cell tumors induced in hairless mice with ultraviolet light. J Invest Dermatol. 1960;34:131-138.

• 摘要

25.  Nomura T, Nakajima H, Hongyo T, et al. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice. Cancer Res. 1997;57:2081-2084.

• 全文
• 摘要

26.  Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351:453-456.

• 摘要

27.  Fu W, Cockerell CJ. The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol. 2003;139:66-70.

• 摘要

28.  Del Rosso JQ. Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference. Cutis. 2011;88:suppl 1-8.

• 摘要

29.  Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell. 1992;70:523-526.

• 摘要

30.  Lane DP. Cancer. p53, guardian of the genome. Nature. 1992;358:15-16.

• 摘要

31.  Satchell AC, Barnetson RS, Halliday GM. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma. Br J Dermatol. 2004;151:42-49.

• 摘要

32.  Clifford JL, Walch E, Yang X, et al. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res. 2002;8:2067-2072.

• 全文
• 摘要

33.  Yaar M, Karassik RL, Schnipper LE, et al. Effects of alpha and beta interferons on cultured human keratinocytes. J Invest Dermatol. 1985;85:70-74.

• 摘要

34.  Bromberg JF, Horvath CM, Wen Z, et al. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A. 1996;93:7673-7678.

• 全文
• 摘要

35.  Smit NP, Vink AA, Kolb RM, et al. Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem Photobiol. 2001;74:424-430.

• 摘要

36.  Ortonne JP. Photoprotective properties of skin melanin. Br J Dermatol. 2002;146(suppl 61):7-10.

• 摘要

37.  Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol. 1994;131:455-464.

• 摘要

38.  Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed). 1988;296:13-17.

• 全文
• 摘要

39.  Marks R, Jolley D, Lectsas S, Foley P. The role of childhood exposure to sunlight in the development of solar keratoses and non-melanocytic skin cancer. Med J Aust. 1990;152:62-66.

• 摘要

40.  Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4-7.

• 摘要

41.  Stockfleth E, Ulrich C, Meyer T, et al. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res. 2002;160:251-258.

• 摘要

42.  Ulrich C, Schmook T, Sachse MM, et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg. 2004;30:622-627.

• 摘要

43.  Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147-1151.

• 摘要

44.  Naylor MF, Boyd A, Smith DW, et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131:170-175.

• 摘要

45.  Rigel DS. Photoprotection: a 21st century perspective. Br J Dermatol. 2002;146(suppl 61):34-37.

• 摘要

46.  Black HS, Herd JA, Goldberg LH, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med. 1994;330:1272-1275.

• 摘要

47.  de Berker D, McGregor JM, Hughes BR; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156:222-230.

• 全文
• 摘要

48.  Zalaudek I, Giacomel J, Argenziano G, et al. Dermoscopy of facial nonpigmented actinic keratosis. Br J Dermatol. 2006;155:951-956.

• 摘要

49.  Zalaudek I, Giacomel J, Schmid K, et al. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: A progression model. J Am Acad Dermatol. 2012;66:589-597.

• 摘要

50.  Quaedvlieg PJ, Tirsi E, Thissen MR, et al. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol. 2006;16:335-339.

• 摘要

51.  Elder DE, Elenitsas R, Johnson Jr. BL, et al. Lever's histopathology of the skin. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

52.  Stolz W, Braun-Falco O, Bilek P, et al. Color atlas of dermatoscopy. 1st ed. London, UK: Blackwell Science Ltd; 1994.

53.  Menzies SW, Crotty KA, Ingvar C, et al. An atlas of surface microscopy of pigmented skin lesions. 1st ed. Sydney, Australia: McGraw-Hill Book Company Australia Pty Limited; 1996.

54.  Donnelly AM, Halbert AR, Rohr JB. Discoid lupus erythematosus. Australas J Dermatol. 1995;36:3-10.

• 摘要

55.  Weber F, Fritsch P. Clinical differential diagnosis of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzica T, eds. Cutaneous lupus erythematosus. Berlin: Springer-Verlag; 2005.

56.  Kontos AP, Jirsari M, Jacobsen G, et al. Immunoglobulin M predominance in cutaneous lupus erythematosus. J Cutan Pathol. 2005;32:352-355.

• 摘要

57.  Zedek DC, Smith ET Jr, Hitchcock MG, et al. Cutaneous lupus erythematosus simulating squamous neoplasia: the clinicopathologic conundrum and histopathologic pitfalls. J Am Acad Dermatol. 2007;56:1013-1020.

• 摘要

58.  Perniciaro C, Randle HW, Perry HO. Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma. Dermatol Surg. 1995;21:255-257.

• 摘要

59.  Uitto J, Santa-Cruz DJ, Eisen AZ, et al. Verrucous lesion in patients with discoid lupus erythematosus. Clinical, histopathological and immunofluorescence studies. Br J Dermatol. 1978;98:507-520.

• 摘要

60.  Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin. 2002;20:378-385.

• 摘要

61.  Reid C. Drug treatment of cutaneous lupus. Am J Clin Dermatol. 2000;1:375-379.

• 摘要

62.  Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus. 1997;6:96-104.

• 摘要

63.  Sontheimer RD. Subacute cutaneous lupus erythematosus: a decade's perspective. Med Clin North Am. 1989;73:1073-1090.

• 摘要

64.  Telfer NR, Chalmers RJ, Whale K, et al. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992;128:39-42.

• 摘要

65.  Christophers E, Kiene P. Guttate and plaque psoriasis. Dermatol Clin. 1995;13:751-756.

• 摘要

66.  Mehregan DR, Hamzavi F, Brown K. Large cell acanthoma. Int J Dermatol. 2003;42:36-39.

• 摘要

67.  Roewert HJ, Ackerman AB. Large-cell acanthoma is a solar lentigo. Am J Dermatopathol. 1992;14:122-132.

• 摘要

68.  Sanchez Yus E, del Rio E, Requena L. Large-cell acanthoma is a distinctive condition. Am J Dermatopathol. 1992;14:140-147.

• 摘要

69.  Rahbari H, Pinkus H. Large cell acanthoma. One of the actinic keratoses. Arch Dermatol. 1978;114:49-52.

• 摘要

70.  Sanchez Yus E, de Diego V, Urrutia S. Large cell acanthoma. A cytologic variant of Bowen's disease? Am J Dermatopathol. 1988;10:197-208.

• 摘要

71.  Uhlenhake EE, Sangueza OP, Lee AD, et al. Spreading pigmented actinic keratosis: a review. J Am Acad Dermatol. 2010;63:499-506.

• 摘要

72.  Yantsos VA, Conrad N, Zabawski E, et al. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg. 1999;18:3-14.

• 摘要

73.  Carag HR, Prieto VG, Yballe LS, et al. Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol. 2000;136:471-475.

• 全文
• 摘要

74.  Scurry J. Grading of actinic keratoses. J Am Acad Dermatol. 2001;44:1052-1053.

• 摘要

75.  European Dermatology Forum. Evidence and consensus based (S3) guidelines for the treatment of actinic keratosis. 2015. http://www.euroderm.org (last accessed 26 September 2016).

• 全文

76.  Gupta AK, Paquet M, Villanueva E, et al. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;(12):CD004415.

• 全文
• 摘要

77.  Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison. Dermatol Surg. 2000;26:728-732.

• 摘要

78.  Touma D, Yaar M, Whitehead S, et al. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140:33-40.

• 全文
• 摘要

79.  Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47:258-262.

• 摘要

80.  Braathen LR, Szeimies RM, Basset-Seguin N, et al; International Society for Photodynamic Therapy in Dermatology. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125-143.

• 摘要

81.  Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140:41-46.

• 全文
• 摘要

82.  Fayter D, Corbett M, Heirs M, et al. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Assess. 2010;14:3-129.

• 摘要

83.  Tierney E, Barker A, Ahdout J, et al. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging. Dermatol Surg. 2009;35:725-746.

• 摘要

84.  Hauschild A, Stockfleth E, Popp G, et al. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol. 2009;160:1066-1074.

• 摘要

85.  Askew DA, Mickan SM, Soyer HP, et al. Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials. Int J Dermatol. 2009;48:453-463.

• 摘要

86.  Kaur RR, Alikhan A, Maibach HI. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment. J Dermatolog Treat. 2010;21:267-271.

• 摘要

87.  Dummer R, Urosevic M, Kempf W, et al. Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol. 2003;149(suppl 66):57-58.

• 摘要

88.  Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol. 2002;138:1498-1502.

• 摘要

89.  Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial. J Am Acad Dermatol. 2002;47:571-577.

• 摘要

90.  Lebwohl M, Dinehart S, Whiting D, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004;50:714-721.

• 摘要

91.  Szeimies RM, Gerritsen MJ, Gupta G, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004;51:547-555.

• 摘要

92.  Gupta AK, Davey V, Mcphail H. Evaluation of the effectiveness of imiquimod and topical fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies. J Cutan Med Surg. 2005;9:209-214.

• 摘要

93.  Falagas ME, Angelousi AG, Peppas G. Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2006;55:537-538.

• 摘要

94.  Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol. 2006;126:1251-1255.

• 全文
• 摘要

95.  Stockfleth E, Christophers E, Benninghoff B, et al. Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study. Arch Dermatol. 2004;140:1542.

• 摘要

96.  Swanson N, Abramovits W, Berman B, et al. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. J Am Acad Dermatol. 2010;62:582-590.

• 摘要

97.  Hanke CW, Beer KR, Stockfleth E, et al. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol. 2010;62:573-581.

• 摘要

98.  An KP, Athar M, Tang X, et al. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem Photobiol. 2002;76:73-80.

• 摘要

99.  Denkert C, Kobel M, Berger S, et al. Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res. 2001;61:303-308.

• 全文
• 摘要

100.  Buckman SY, Gresham A, Hale P, et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis. 1998;19:723-729.

• 全文
• 摘要

101.  Berman B, Villa AM, Ramirez CC. Mechanisms of action of new treatment modalities for actinic keratosis. J Drugs Dermatol. 2006;5:167-173.

• 摘要

102.  Pflugfelder A, Welter AK, Leiter U, et al; German Dermatologic Cooperative Oncology Group. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group. J Eur Acad Dermatol Venereol. 2012;26:48-53.

• 摘要

103.  Nelson C, Rigel D. Long-term follow up of diclofenac sodium 3% in 2.5% hyaluronic acid gel for actinic keratosis: one-year evaluation. J Clin Aesth Dermatol. 2009;2:20-25.

• 全文

104.  Smith SR, Morhenn VB, Piacquadio DJ. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol. 2006;5:156-159.

• 摘要

105.  Iraji F, Siadat AH, Asilian A, et al. The safety of diclofenac for the management and treatment of actinic keratoses. Expert Opin Drug Saf. 2008;7:167-172.

• 摘要

106.  Stockfleth E, Zwingers T, Willers C. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur J Dermatol. 2012;22:370-374.

• 摘要

107.  Siller G, Gebauer K, Welburn P, et al. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study. Australas J Dermatol. 2009;50:16-22.

• 摘要

108.  Anderson L, Schmieder GJ, Werschler WP, et al. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. J Am Acad Dermatol. 2009;60:934-943.

• 摘要

109.  Lebwohl M, Swanson N, Anderson LL, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010-1019.

• 全文
• 摘要

110.  Fewkes JL, Cheney ML, Pollack SV. Dermabrasion. In: Illustrated atlas of cutaneous surgery. 1st ed. Philadelphia, PA: J.B. Lippincott Company; 1992:26.1-26.11.

111.  Esser, AC, Harmon CB. Complications of dermabrasion. In: Nouri K, ed. Complications of dermatologic surgery. Philadelphia, PA: Mosby Elsevier; 2008:207-217.

112.  Harmon CB. Dermabrasion. Dermatol Clin. 2001;19:439-442;viii.

• 摘要

113.  Orenstein A, Goldan O, Weissman O, et al. A new modality in the treatment of actinic cheilitis using the Er:YAG laser. J Cosmet Laser Ther. 2007;9:23-25.

• 摘要

114.  Peterson SR, Goldberg LH. New and emerging treatments for nonmelanomas and actinic keratoses. J Drugs Dermatol. 2003;2:429-432.

• 摘要

115.  McMahon AP. More surprises in the Hedgehog signaling pathway. Cell. 2000;100:185-188.

• 摘要

116.  Miller SJ, Yu TC. Cyclopamine as a potential therapeutic agent for treatment of tumors related to hedgehog pathway mutations. Dermatol Surg. 2002;28:187.

• 摘要

117.  Tas S, Avci O. Rapid clearance of psoriatic skin lesions induced by topical cyclopamine. A preliminary proof of concept study. Dermatology. 2004;209:126-131.

• 摘要

118.  Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272:1668-1671.

• 摘要

119.  Surjana D, Halliday GM, Martin AJ, et al. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol. 2012;132:1497-1500.

• 摘要

120.  Stockfleth E, Kerl H, Zwingers T, et al. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Br J Dermatol. 2011;165:1101-1108.

• 摘要

121.  Ghuznavi N, Nocera NF, Guajardo AR, et al. Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma. Clin Investig. 2012;2:909-921.

122.  All Wales Therapeutics and Toxicology Centre. AWMSG Secretariat assessment report (Limited submission), Advice no. 1012: Fluorouracil/salicylic acid (Actikerall®). March 2012. http://www.wales.nhs.uk (last accessed 26 September 2016).

• 全文

123.  Schmieder GJ, Huang EY, Jarratt M. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period. J Drugs Dermatol. 2012;11:1483-1489.

• 摘要

124.  Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-797.

• 摘要

125.  Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:23-24.

• 摘要

126.  Marks R, Foley P, Goodman G, et al. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 1986;115:649-655.

• 摘要

127.  Suchniak JM, Baer S, Goldberg LH. High rate of malignant transformation in hyperkeratotic actinic keratoses. J Am Acad Dermatol. 1997;37:392-394.

• 摘要

128.  Ehrig T, Cockerell C, Piacquadio D, et al. Actinic keratoses and the incidence of occult squamous cell carcinoma: a clinical-histopathologic correlation. Dermatol Surg. 2006;32:1261-1265.

• 摘要

129.  Kinlen LJ, Sheil AG, Peto J, et al. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979;2:1461-1466.

• 全文
• 摘要

130.  Blohme I, Larko O. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy. Acta Derm Venereol. 1990;70:491-494.

• 摘要

131.  Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet. 1971;2:1282-1283.

• 摘要

132.  Hardie IR, Strong RW, Hartley LC, et al. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery. 1980;87:177-183.

• 摘要

133.  Bouwes Bavinck JN, Hardie DR, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996;61:715-721.

• 摘要

134.  Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol. 2000;42:25-28.

• 摘要

135.  Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7:631-632.

• 摘要

136.  Thai KE, Fergin P, Freeman M, et al A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43:687-692.

• 摘要

137.  Zouboulis CC, Rohrs H. Cryosurgical treatment of actinic keratoses and evidence-based review. Hautarzt. 2005;56:353-358.

• 摘要

138.  Stockfleth E, Kerl H; Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses. Eur J Dermatol. 2006;16:599-606.

• 摘要

139.  Cox NH, Eedy DJ, Morton CA; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol. 2007;156:11-21.

• 摘要

140.  Montgomery H, Dorffel J. Verruca senilis und keratoma senile. Arch f Dermat u Syphil (Berlin). 1932;166:286-297.

141.  Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;269:976-990.

• 摘要

142.  Czarnecki D, Staples M, Mar A, et al. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology. 1994;189:52-54.

• 摘要

143.  Lang K, Schulte KW, Ruzicka T, et al. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses. Skin Therapy Lett. 2001;6:1-2;5.

• 摘要

144.  North P, Zembowicz A, Mihm M, et al. Sun induced skin diseases. Pathol Int. 2004;54:S559-S569.

145.  Monheit GD. Medium-depth chemical peels. Dermatol Clin. 2001;19:413-425;vii.

• 摘要

146.  Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25:18-22.

• 摘要

147.  Kligman D, Kligman AM. Salicylic acid peels for the treatment of photoaging. Dermatol Surg. 1998;24:325-328.

• 摘要

148.  Ghersetich I, Teofoll P, Gantcheva M, et al. Chemical peeling: how, when, why? J Eur Acad Dermatol Venereol. 1997;8:1-11.

149.  Rubin MG. Salicylic acid peels (nonfacial). In: Rubin MG, ed. Manual of chemical peels. Superficial and medium depth. 1st ed. Philadelphia, PA: J.B. Lippincott Company; 1995:103-109.

150.  Dolezal J. Jessner's peels. In: Rubin MG, ed. Manual of chemical peels. Superficial and medium depth. 1st ed. Philadelphia, PA: J.B. Lippincott Company; 1995:79-88.